Quick Answer
Tyra Biosciences, Inc. reported Common Stock Shares Outstanding of 53.71 million shares for the year ending 2025.
- Tyra Biosciences, Inc. showed an increase of +5.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Tyra Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: 41.21 million shares | Q1 2022: 41.70 million shares | Q2 2022: 41.90 million shares | Q3 2022: 42.14 million shares | Q1 2023: 42.54 million shares | Q2 2023: 42.82 million shares | Q3 2023: 42.93 million shares | Q1 2024: 52.47 million shares | Q2 2024: 52.74 million shares | Q3 2024: 52.87 million shares | Q1 2025: 53.09 million shares | Q2 2025: 53.23 million shares | Q3 2025: 53.32 million shares.
- Over the full 6 years of available data (2020 to 2025), Tyra Biosciences, Inc.'s Common Stock Shares Outstanding has grown by 2,835.8%.
- Historical annual values: Fiscal year 2025: 53.71 million shares | Fiscal year 2024: 50.75 million shares | Fiscal year 2023: 43.02 million shares | Fiscal year 2022: 42.35 million shares | Fiscal year 2021: 41.44 million shares | Fiscal year 2020: 1.83 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: